NDC 85237-1896-01 - Theraflu Severe Cold Relief Daytime
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1896
- Requested NDC
- 85237-1896-01
- Package NDCs from labels
- 85237-1896-0, 85237-1896-1, 85237-1896-3, 85237-1896-01
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-07-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Theraflu Severe Cold Relief Daytime - Select Consumer Group | Select Consumer Group | 2026-07-06 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens Allergy | DIPHENHYDRAMINE HYDROCHLORIDE | AptaPharma Inc. | b2cef61f-ab54-4a20-a7f7-6d3da4754e8b | 2025-12-26 | Warnings | M012 |
| CHILDRENS MUCUS RELIEF COUGH - CHERRY FLAVOR | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | AptaPharma Inc. | 9ae6fe74-80cd-482a-b3b9-3acafd6708ec | 2025-12-26 | Warnings | M012 9D2RTI9KYH |
| Tussin Expectorant | GUAIFENESIN | AptaPharma, Inc. | ca8fa216-09c1-42b2-a95b-fa3d0f13363c | 2025-12-26 | Warnings | M012 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Pioneer Life Sciences, LLC | aa2de3a5-a20d-33c6-e053-2a95a90ada3e | 2025-12-26 | Warnings | 362O9ITL9D |
| Childrens Pain and Fever | ACETAMINOPHEN | Discount Drug Mart | 2aa0f9f3-924c-4a4a-bb5f-2a326acc2408 | 2025-12-26 | Warnings | 362O9ITL9D |
| Gencare DayTime Cold and Flu Softgel | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Pioneer Life Sciences, LLC | a9875dc9-6a27-413c-a2c7-68a86483ffc1 | 2025-12-26 | Warnings | M012 9D2RTI9KYH 362O9ITL9D |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 3b7e0ee7-4dda-4bbe-842c-6cbbc208acd5 | 2025-12-26 | Warnings | M012 |
| GenCare Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Pioneer Life Sciences, LLC | 667f6f1b-5179-481c-a131-940c7937aada | 2025-12-26 | Warnings | 362O9ITL9D |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 0d604fc6-7bb9-4f7c-99cd-fdae4df4bb6f | 2025-12-26 | Warnings | M012 |
| Mucus Relief DM | DEXTROMETHORPHAN HBR 20MG GUAIFENESIN 400MG | Pioneer Life Sciences, LLC | 3ce0f096-906e-47eb-8061-0ac1e9d8ea55 | 2025-12-26 | Warnings | M012 9D2RTI9KYH |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 1194c338-e115-4105-93d8-9ab833c43193 | 2025-12-26 | Warnings | M012 |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 9c9e558d-d991-4a2e-aa13-37c0b08071e6 | 2025-12-26 | Warnings | M012 |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 1695e7ea-2f83-4d3a-980e-c91be6c1f2a5 | 2025-12-25 | Warnings | M012 |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | RedPharm Drug | 2c6014de-8901-9d83-e063-6294a90ad37b | 2025-12-25 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Pharbetol | ACETAMINOPHEN | Pharbest Pharmaceuticals, Inc. | 04dbd98f-c74d-43b2-8bda-74f18be7cf6c | 2025-12-24 | Warnings | 362O9ITL9D |
| CETAFEN EXTRA | ACETAMINOPHEN | HART Health | 38db0b09-37f8-4fed-903e-81e89486b39b | 2025-12-24 | Warnings | 362O9ITL9D |
| GUAIFENESIN | GUAIFENESIN | Pharbest Pharmaceuticals, Inc. | 0bf70fb4-d3c8-476d-b864-4eadc697a7d8 | 2025-12-24 | Warnings | M012 |
| CETAFEN | ACETAMINOPHEN | HART Health | c1162bab-377d-4e17-9417-ccd20d29148b | 2025-12-24 | Warnings | 362O9ITL9D |
| StellaLife VEGA Oral Care | SPRAY | StellaLife, Inc. | b8ba495e-2cfe-092c-e053-2995a90a3fd3 | 2025-12-24 | Warnings | ETJ7Z6XBU4 |
| StellaLife VEGA Oral Care Recovery Kit | KIT | Homeocare Laboratories, Inc. | b701234a-0bd2-16d3-e053-2995a90a5b13 | 2025-12-24 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.